Hafnia alvei HA4597


Hafnia alvei is the first precision probiotic developed based on a target-based approach and a screening for strains producing ClpB, a protein mimicking alpha-MSH and activating the signals of satiety. Its mechanism of action and demonstration in efficacy in mice and humans make it a uniquely positioned, innovative next-gen probiotic for weight management.

Scientific reference(s)

Additional info

Therapeutical area(s)

Cardiometabolic · Gut brain Axis · Weight management




Adults · Women
Scroll to Top
Browse companies by type
Brought to you by